Several HASPIN inhibitors have since been characterized, and their antiproliferative effects against a wide range of human cancer cell types have been reported, including colon, breast, prostate, skin, pancreas, lung, ovary, bladder, biliary tract, and hematopoietic system cancers [10]. The gene discussed is HASPIN; the disease is cancer.